All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ABBV total return snapshot: ABBV returned +38.97% over the past year and +28.92% YTD, with dividends reinvested. Since Dec. 10, 2012, ABBV is up +1,314.32% in nominal total return, or +21.00%/yr, and is currently −3.01% below its total-return high on Oct. 30, 2026.
Data ending Tue Nov. 3, 2026
| Mon 2012-12-10💬 to Tue 2026-11-03 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+1,314.32%
+21.00%/yr |
+17.93%/yr
R2=0.965 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10💬 to Tue 2026-11-03 |
Start
Value |
End
Value |
|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$141,431.52
2026-11-03 |
| YTD | YoY | |
|---|---|---|
| ABBV × | +28.92% | +38.97% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| ABBV × |
−3.01%
on 2026-11-03 from 2026-10-30 peak |
−45.09%
on 2019-08-15 from 2018-01-26 peak |
| Period ending Tue 2026-11-03 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| ABBV × | +38.97% |
+49.77% +22.38%/yr |
+123.45% +30.74%/yr |
+190.53% +23.78%/yr |
+669.05% +22.63%/yr |
| Year | ABBV |
|---|---|
| 2026 (YTD) | +28.92% |
| 2025 | +33.08% |
| 2024 | +18.86% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.07% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
